AG0039KU

152-11-4 | 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile hydrochloride

Chemical structure of 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile hydrochloride, CAS 152-11-4
AG0039KU
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 152-11-4
Catalog Number AG0039KU(AGN-PC-0Q69FZ)
Chemical Name 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile hydrochloride
IUPAC Name 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile;hydrochloride
InChI InChI=1S/C27H38N2O4.ClH/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6;/h9-12,17-18,20H,8,13-16H2,1-7H3;1H
InChI Key DOQPXTMNIUCOSY-UHFFFAOYSA-N
MDL Number MFCD00055208
Molecular Formula C27H39ClN2O4
Molecular Weight 491.0626
SMILES N#CC(C(C)C)(C1=CC=C(OC)C(OC)=C1)CCCN(CCC2=CC=C(OC)C(OC)=C2)C.[H]Cl
Synonyms
Calan, Cordilox, Dexverapamil, Falicard, Finoptin, Hydrochloride, Verapamil, Iproveratril, Isoptin, Isoptine, Izoptin, Lekoptin, Verapamil, Verapamil Hydrochloride, Verapamil hydrochloride, Verapamil HCl, 152-11-4, Manidon, Calcan hydrochloride, Cordilox, Cardibeltin, Cardiabeltin, Cardioprotect, Veroptinstada, Calaptin, Caveril, Civicor, Coraver, Corpamil, Durasoptin, Harteze, Hexasoptin, Hormitol, Ikapress, Inselon, Isoptino, Jenapamil, Lodixal, Magotiron, Praecicor, Robatelan, Vasomil, Vasopten, Verabeta, Veracor, Verahexal, Veraloc, Veramil, Verapin, Verasal, Verasifar, Veratensin, Verdilac, Vetrimil, Elthon, Flamon, Ikacor, Univex, Vortac, (+/-)-VERAPAMIL HYDROCHLORIDE, Anpec, Ormil, Rapam, Verapamil Ebewe, Verapamil Riker, Verapamil Verla, Civicor Retard, Isoptin Retard, Manidon Retard, Vera-Sanorania, Verapamil Acis, Verapamil Atid, Verapamil Basics, Verapamil Nordic, Verapamil-AbZ, Novapamyl LP, Verapamil NM, Verapamil PB, Verapamil SR, Cordilox SR, Dilacoran HTA, Veracaps SR, Verapamil MSD, Hexasoptin Retard, Verapamil Henning, Arpamyl LP, Verelan SR, Verapamil Injection, Berkatens, Cardiagutt, Dignover, Geangin, Izoptin, Lekoptin, Veramex, Verpamil, Akilen, Quasar, Univer, Verapamil chloridrate, Verapamil NM Pharma, Calaptin 240 SR, Novo-Veramil, Verapress 240 SR, D-365 hydrochloride, Verapamil AL, Verapamyl hydrochloride, Apo-Verap, Isoptin SR, Nu-Verap, Covera-HS, Calan SR, 23313-68-0, Iproveratril hydrochloride, Verapamil (hydrochloride), HSDB 3928, EINECS 205-800-5, NSC 272366, LU 20175, MLS000069485, (+/-)-Verapamil, Hydrochloride, NSC 135784, MFCD00055208, NSC657799, Verapamil Hydrochloride (Isoptin, Iproveratril, Calan), SMR000059109, 38176-10-2, 5-((3,4-dimethoxyphenethyl)(methyl)amino)-2-(3,4-dimethoxyphenyl)-2-isopropylpentanenitrile hydrochloride, 5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile monohydrochloride, Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)-, monohydrochloride, Q-201923, (+/-)-Verapamil hydrochloride, 99+%, (+-)-5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile monohydrochloride, 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile hydrochloride, 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl]methylamino}-2-(methy lethyl)pentanenitrile, chloride, Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)-, monohydrochloride, (+-)-, Valeronitrile, 5-((3,4-dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropyl-, monohydrochloride, NSC272366, SR-01000000050, Covera, verapami-hcl, Verapamil, HCl, 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile;hydrochloride, Prestwick_440, Vasolan (TN), Verapamil hydrochloride [USAN:JAN], Verelan (TN), Covera-hs (TN), Calan (TN), Isotopin hydrochloride, Verapamil hydrochloride [USAN:USP:JAN], Opera_ID_1210, ()-Verapamil hydrochlorid, CAS-152-11-4, (y)-Verapamil hydrochloride, AC1L1Y4V, AC1Q3CE8, (?)-Verapamil hydrochloride, CHEMBL1280, DSSTox_CID_14095, DSSTox_RID_79114, Verapamil Hydrochloride,(S), DSSTox_GSID_34095, SCHEMBL33296, C27H39ClN2O4, MLS001055442, MLS002222213, (+-)-Verapamil hydrochloride, (??)-Verapamil hydrochloride, ARONIS24174, C27H38N2O4.HCl, SPECTRUM2300307, DTXSID2034095, BBC/320, BIV1326, DOQPXTMNIUCOSY-UHFFFAOYSA-N, ZX-AFC000544, HMS1568M04, HMS1922J16, Pharmakon1600-02300307, BCP06465, HY-A0064, ZX-AS004533, Tox21_201180, Tox21_501237, BG0353, CCG-39491, IN1425, NSC759589, s4202, Verapamil hydrochloride (JP17/USP), AKOS005267117, AC-8483, AN-7969, API0024301, CS-1685, LP01237, NSC-272366, NSC-657799, NSC-759589, NCGC00024710-03, NCGC00094479-01, NCGC00094479-02, NCGC00094479-03, NCGC00094479-04, NCGC00094479-05, NCGC00258732-01, NCGC00261922-01, AC-16228, AK124375, AS-16018, BC210130, CC-35585, R853, SC-18887, ST066908, AB0018370, LS-161199, EU-0101237, FT-0603360, FT-0655647, ST24050346, SW196662-4, 36622-29-4, D00619, EN300-124002, K-4825, V 4629, ( inverted question mark)-Verapamil hydrochloride, 54236-EP2305219A1, 54236-EP2308562A2, 152V114, A816666, I06-0615, SR-01000000050-2, SR-01000000050-4, SR-01000000050-11, Z2210978706, (+/-)-Verapamil hydrochloride, >=99% (titration), powder, Verapamil Hydrochloride 1.0 mg/ml in Methanol (as free base), Verapamil hydrochloride, European Pharmacopoeia (EP) Reference Standard, Verapamil hydrochloride, United States Pharmacopeia (USP) Reference Standard, (+/-)-Verapamil hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material, 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-isopropyl-pentanenitrile hydrochloride, 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-propan-2-yl-pentanenitrile hydrochloride, 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile hydrochloride, 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-isopropylpentanenitrile hydrochloride, 5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxy phenyl)-2-isopropylvaleronitrile hydrochloride, 5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile Hydrochloride, Benzeneacetonitrile,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-.alpha.-(1-methylethyl)-, monohydrochloride, Valeronitrile, 5-((3,4-dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropyl-,monohydrochloride, Verapamil hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Falicard, Finoptin, Isoptine, Isoptin, Securon, Verelan, Calan, Tarka, Verelan PM, Vasolan, (R)-Gallopamil, (+)-Gallopamil, VERAPAMIL, Gallopamil, (+)-, (+)-Methoxyverapamil, UNII-V8KE5XTM0I, UNII-V3888OEY5R, R(+)-VERAPAMIL, VERAPAMILHYDROCHLORIDE, C27H38N2O4.ClH, V3888OEY5R, (S)-(-)-Verapamil Hydrochloride, CID62969, C27-H38-N2-O4.Cl-H, EINECS 245-579-2, CS-O-02558, D-D-600, V0118, (+)-D 600, Verapamil hydrochloride, 98%, a L-type Ca2 channel blocker - 1G 1g, (+-)-[3-cyano-3-(3,4-dimethoxyphenyl)hex-6-yl](5,6-dimethoxyphenethyl)methylammonium chloride, (1)-(3-Cyano-3-(3,4-dimethoxyphenyl)hex-6-yl)(5,6-dimethoxyphenethyl)methylammonium chloride, ?-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-?-(1-methylethyl)benzeneacetonitrile hydrochloride, 2-(3,4-dimethoxyphenyl)-5-[[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino]-2-isopropylpentanenitrile hydrochloride, 5-[N-(3,4-Dimethoxyphenylethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile hydrochloride, alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)methylamino)propyl)-3,4,5-trimethoxy-alpha-(1-methylethyl)benzeneacetonitrile, (R)-, Bencenacrilonitrilo, alfa-[3-[[2-(3,4-dimetoxifenil) etil] metilamino] propil]-3,4-dimetoxi-alfa-(1-metiletil)-, clorhidrato (1:1), Benzeneacetonitrile, .alpha.-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-.alpha.-(1-methylethyl)-, monohydrochloride, Benzeneacetonitrile, ?-[3-[[2-(3,4-dimethoxyphenyl) ethyl]methylamino]propyl]-3,4-dimethoxy -?-(1-methylethyl)-, monohydrochloride, Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-3,4,5-trimethoxy-alpha-(1-methylethyl)-, (alphaR)-,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited